Important Notice:
- According to the "Notice on the Trading System Arrangement for Risk Warning Stocks and Delisting Transition Stocks on the Growth Enterprise Market," the trading mechanism for the company's stock during the delisting transition period will follow the provisions of the "Shenzhen Stock Exchange Trading Rules." The price fluctuation limit during the delisting transition period remains unchanged at 10%.
- Hunan Qianshan Pharmaceutical Machinery Co., Ltd. received the Shenzhen Stock Exchange's decision on the termination of its stock listing on July 14, 2020. The company's stock will enter the delisting transition trading period starting from the next trading day after the fifteenth trading day following the decision (i.e., August 5, 2020). As of September 1, 2020 (inclusive), 20 trading days have been completed, with 10 trading days remaining. Investors are advised to invest cautiously and pay attention to risks.
- During the delisting transition trading period, the company will not plan or implement any major asset restructuring matters.
- According to Article 2 of the "Implementation Measures for the Re-listing of Delisted Companies on the Shenzhen Stock Exchange (Revised in 2018)," the Shenzhen Stock Exchange's Growth Enterprise Market does not accept applications for the re-listing of the company's stock. Therefore, the company's stock cannot be relisted after delisting. Investors are advised to pay attention to risks and invest rationally.
- The company's stock is classified as a special security under the Shenzhen Stock Connect. Investors in the Shenzhen Stock Connect can choose to sell their holdings during the delisting transition period but cannot purchase the company's stock. After the stock is delisted and enters the share transfer system, investors in the Shenzhen Stock Connect may be unable to transfer their shares. Investors are advised to be aware of investment risks.
Hunan Qianshan Pha